- This event has passed.
SBIR/STTR Proposal Preparation Training
January 22, 2020 @ 9:00 am - January 23, 2020 @ 5:00 pm EST
Agenda – download
The workshop will end with 1-on-1 assessments that allow competitive applications to receive free support for April 5 submission. If you have an idea you would like to share with us for the assessment, please fill out the assessment form by January 21.
BioGenerator and BBC bring this workshop to cover all aspects of writing an SBIR/STTR proposal focused on life science technologies. The workshop will include information on the National Institutes of Health and the National Science Foundation programs, though it is timed to aid in proposal preparation for the April 5, 2020, NIH deadline and detailed emphasis will be placed on the NIH process.
Training will begin with SBIR/STTR basics, including eligibility requirements, participating agencies, difference between SBIR/STTR, and essential information about the NSF program.
Free parking is available on Forest Park Avenue east of S. Sarah Street and at IKEA. Please plan to arrive early to find parking.
The workshop is conducted by SBIR/STTR expert, Shannon Bass, Principal Consultant at BBC, with a background of management in the biotechnology industry. Shannon has assisted numerous start-ups in developing competitive NIH grant submissions, post-award management, commercialization, and project management. Grant and contracts management expert, Kris Bergman, will provide the budget preparation webinar on January 23. Both Shannon and Kris are with BBC Entrepreneurial Training & Consulting (BBCetc – www.bbcetc.com), which is nationally recognized for its expertise in helping emerging companies win federal funding through the SBIR and STTR programs.
“Excellent content. This should be a MUST for anyone applying to fed grants” – Primary Investigator developing a therapy for neonates
“Great Seminar!”- PhD student at Washington University
(This workshop is a part of Grants2Business, a highly successful program with an average NIH SBIR success rate of 37% (16% national average, 2017) for Phase I and 60% (38% national average, 2017) for Phase II submissions.)